Viamet Pharmaceuticals Garners $7,000,000 Series C Round

  • Feed Type
  • Date
  • Company Name
    Viamet Pharmaceuticals
  • Mailing Address
    4505 Emperor Blvd. Durham, NC 27703 USA
  • Company Description
    Viamet Pharmaceuticals discovers and develops best-in-class inhibitors of validated metalloenzymes via an innovative and proprietary metal-binding approach, our Metallophile Technology.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
    Series C
  • Proceeds Purposes
    Proceeds purposes were not disclosed. SEC regulatory filing-amended.
  • M&A Terms
  • Venture Investor

Trending on Xconomy